Dr. Joseph Rocco Pisegna, MD

Dr. Pisegna practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Pisegna's NPI, 1295755882, was assigned on July 19, 2006. Dr. Pisegna graduated from University of Miami, Miller School of Medicine in 1986. Dr. Pisegna's California license number on file is G72435.

Dr. Pisegna's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Pisegna's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Pisegna is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Pisegna to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pisegna practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Pisegna's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Pisegna is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Pisegna's licenses on file in 6 states: California, Florida, Nevada, Virginia, Maryland and District of Columbia.

Dmand AI lists acid reflux, acute gastroduodenitis and gastrointestinal bleeding among the conditions Dr. Pisegna treats.

CMS data shows 17 Medicare services from Dr. Pisegna across 1 procedure code in 2024, all of them office visits, for 23 Medicare patients. Medicare paid $1,153 for them. Every service was in an office.

CMS counts 23 Medicare patients who saw Dr. Pisegna in 2024. 65% of them have high cholesterol, and 61% have arthritis. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pisegna's median patient age at 63, with 63% women.

In 2024, Dr. Pisegna wrote 91 Medicare Part D claims for 14 patients. 29% of them were for generic drugs. CMS names the drug for 49 of them, across 3 drugs with 11 or more claims each, at $67,366 in total drug cost. In 2023, CMS named 91 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Pisegna for performance year 2024, reported as part of a group. Dr. Pisegna accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pisegna as offering telehealth.

Dmand AI links 19 papers to Dr. Pisegna, published from 2017 to 2025. 2018 was the busiest year, with 4. Dr. Pisegna's most frequent co-authors are Jihane Nejma Benhammou, BS, Elizabeth Stanton Teter Aby, MD and Surinder K. Batra, MD.

Dmand AI links Dr. Pisegna to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Gastroesophageal Reflux, Obesity and Rectal Diseases. VA Office of Research and Development sponsors the most, 2.

CMS Open Payments shows 427 general payments to Dr. Pisegna from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Phathom Pharmaceuticals, Inc. paid the most, $146,974. It also lists 6 research payments totaling $1,630 in 2019.

Dmand AI lists 6 awards for Dr. Pisegna, most recently Member in 2019.

Dr. Pisegna graduated from University of Miami, Miller School of Medicine in 1986. Dr. Pisegna is a member of AOA, ACG and AGA.

Dr. Pisegna is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.